Cytokines Linked With Survival Outcomes in Nivolumab-Treated mRCC
Molecular biomarkers are needed to assess disease prognosis in patients with metastatic clear cell renal cell carcinoma treated with nivolumab.
Stay updated with breaking news from Database Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Molecular biomarkers are needed to assess disease prognosis in patients with metastatic clear cell renal cell carcinoma treated with nivolumab.
Molecular biomarkers are needed to assess disease prognosis in patients with metastatic clear cell renal cell carcinoma treated with nivolumab.
Real-world data confirm pazopanib to be safe and effective in patients with metastatic renal cell carcinoma.
/PRNewswire/ -- The COVID-19 Research Database, a pro bono initiative led by numerous leading healthcare organizations, including Change Healthcare, Datavant,...
Press release content from PR Newswire. The AP news staff was not involved in its creation.